Jamaica vs Slovenia: Cause of death, by non-communicable diseases, female
Jamaica
74.2%
in 2021
Slovenia
74.9%
in 2021
Jamaica rank
67th
Slovenia rank
64th
Cause of death, by non-communicable diseases, female over time
- Jamaica
- Slovenia
How they compare
Slovenia currently reports 74.9% against 74.2% in Jamaica, a difference of 0.7%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Slovenia ahead.
Jamaica ranks 67th and Slovenia ranks 64th of 185 countries.
Across the 3 decades both report, Jamaica averaged higher in 1 and Slovenia in 2.
Head to head by decade
| Decade | Jamaica | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 79.3% | 88.0% | 8.7% | Slovenia |
| 2010s | 83.1% | 90.2% | 7.1% | Slovenia |
| 2020s | 78.9% | 75.5% | 3.5% | Jamaica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Jamaica or Slovenia?
- Slovenia, at 74.9% against 74.2% in Jamaica as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Jamaica and Slovenia?
- 0.7%, with Slovenia ahead.
- How many years of comparable data are there for Jamaica and Slovenia?
- 6 years are reported by both, from 2000 to 2021.
- How do Jamaica and Slovenia rank globally for cause of death, by non-communicable diseases, female?
- Jamaica ranks 67th and Slovenia ranks 64th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.